Coles-led Cerevel Therapeutics to raise $445 million to develop brain drugs with fewer side effects

https://www.statnews.com/2020/07/30/coles-led-cerevel-therapeutics-to-raise-445-million-to-develop-brain-drugs-with-fewer-side-effects/?utm_source=STAT+Newsletters&utm_campaign=0911134328-Daily_Recap&utm_medium=email&utm_term=0_8cab1d7961-0911134328-149692869

STAT Plus: Coles-led Cerevel Therapeutics to raise $445 million to develop brain drugs with fewer side effects

By DAMIAN GARDE AND MATTHEW HERPER

ADOBE

Cerevel Therapeutics, a Boston neuroscience company spun out from Pfizer in 2018 and led by the well-known CEO Tony Coles, is going public.

READ MORE